Japan· JP-3999405A2077
ウリナスタチン
A ulinastatin product containing ウリナスタチン, registered in Japan by 持田製薬, on the national reimbursement list.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- ウリナスタチン
- Manufacturer
- 持田製薬
- Country
- Japan (JP)
- ATC code
- B02AB05
- ATC class
- Ulinastatin
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under B02AB05
Ulinastatin, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d15acde6-055d-42a4-8836-3fcff0f24b2c GET /v1/drugs/d15acde6-055d-42a4-8836-3fcff0f24b2c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "５０，０００単位１ｍＬ１管",
"marks": null,
"source": "mhlw",
"remarks": null,
"yj_code": "3999405A2077",
"category": "注射薬",
"price_yen": 790,
"generic_name": "ウリナスタチン",
"product_name_jp": null,
"therapeutic_class": "3999",
"transitional_expiry": null
}See everything about ulinastatin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.